Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients
1 other identifier
observational
664
1 country
1
Brief Summary
This study aimed to investigate whether hemodynamic status before SBT contributed to the effect of sodium bicarbonate infusion on the risk of neonatal organ dysfunction and mortality in critically ill patients with early metabolic acidosis in ICU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 29, 2021
CompletedFirst Posted
Study publicly available on registry
July 7, 2021
CompletedJuly 7, 2021
June 1, 2021
6 months
June 29, 2021
June 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
newly developed or exacerbated organ dysfunction
We defined a composite of newly "developed or exacerbated organ dysfunction" (d/eOD) as a net increase in Sequential Organ Failure Assessment (SOFA) score ≥2 of at least one organ within 7 days of ICU admission over the baseline (SOFA score in the first 24 hours).
The duration of the database covers from June 2001 to October 2012.
Study Arms (2)
sodium bicarbonate group
Sodium bicarbonate was initiated within 48 hours after ICU admission.
non-sodium bicarbonate group
Patients were not infused with sodium bicarbonate.
Interventions
Eligibility Criteria
We obtained data from the MIMIC-III. The newest version of MIMIC-III, v. 1.4, integrates 61,532 patients admitted to the ICUs of Beth Israel Deaconess Medical Center in Boston, Massachusetts.
You may qualify if:
- (1) pH≤7.3; (2) BE≤-8, or HCO3- \< 20 mmol/L if BE was missing; and (3) PaCO2\< 50 mmHg, or without chronic obstructive pulmonary disease (COPD) in discharge diagnoses if PaCO2 was unavailable.
You may not qualify if:
- (1) age 16 or under; (2) diabetes insipidus ; (3) comorbidity of peripheral paralysis; (4) ICU stay over 100 days; (5) SBT was initiated before ICU admission , later than 48 hours after ICU admission or after a record of order for renal replacement therapy (RRT); and (6) death within the first 24 hours after ICU admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Critical Care Medicine Department
Beijing, Beijing Municipality, 100191, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2021
First Posted
July 7, 2021
Study Start
August 1, 2019
Primary Completion
February 1, 2020
Study Completion
September 1, 2020
Last Updated
July 7, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share